Welcome to the Fall/Winter 2012 issue of our China Life Sciences Newsletter, a periodic update on key developments, companies, and people in the dynamic China life sciences industry. In this issue, we bring you an interview with Dr. Dan Zhang, Founder and CEO of Fountain Medical Development, a full-service clinical CRO, based in South East Asia and China; the second of a three-part series discussing the strategic partnerships between Western and Chinese companies for the purpose of conducting early-stage pharma and biotech R&D (please find the first part in our Spring Issue); an analysis of compulsory patent licensing practices in China; and a discussion of new developments on the "patentable subject matter" requirement of U.S. patent law.
To read our newsletter, click here.
Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Morrison & Foerster LLP. All rights reserved